- Home
- SKYQ vs ALLR Comparison
SKYQ vs ALLR Comparison
Compare SKYQ & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKYQ
- ALLR
- Stock Information
- Founded
- SKYQ 2019
- ALLR 2004
- Country
- SKYQ United States
- ALLR United States
- Employees
- SKYQ N/A
- ALLR N/A
- Industry
- SKYQ
- ALLR Biotechnology: Pharmaceutical Preparations
- Sector
- SKYQ
- ALLR Health Care
- Exchange
- SKYQ NYSE
- ALLR Nasdaq
- Market Cap
- SKYQ 2.0M
- ALLR 2.3M
- IPO Year
- SKYQ N/A
- ALLR N/A
- Fundamental
- Price
- SKYQ $1.90
- ALLR $1.32
- Analyst Decision
- SKYQ
- ALLR
- Analyst Count
- SKYQ 0
- ALLR 0
- Target Price
- SKYQ N/A
- ALLR N/A
- AVG Volume (30 Days)
- SKYQ 173.8K
- ALLR 658.4K
- Earning Date
- SKYQ 11-26-2024
- ALLR 11-14-2024
- Dividend Yield
- SKYQ N/A
- ALLR N/A
- EPS Growth
- SKYQ N/A
- ALLR N/A
- EPS
- SKYQ N/A
- ALLR N/A
- Revenue
- SKYQ $30,766,012.00
- ALLR N/A
- Revenue This Year
- SKYQ N/A
- ALLR N/A
- Revenue Next Year
- SKYQ N/A
- ALLR N/A
- P/E Ratio
- SKYQ N/A
- ALLR N/A
- Revenue Growth
- SKYQ N/A
- ALLR N/A
- 52 Week Low
- SKYQ $1.51
- ALLR $1.26
- 52 Week High
- SKYQ $5.49
- ALLR $666.00
- Technical
- Relative Strength Index (RSI)
- SKYQ N/A
- ALLR 32.39
- Support Level
- SKYQ N/A
- ALLR $1.32
- Resistance Level
- SKYQ N/A
- ALLR $1.53
- Average True Range (ATR)
- SKYQ 0.00
- ALLR 0.12
- MACD
- SKYQ 0.00
- ALLR 0.05
- Stochastic Oscillator
- SKYQ 0.00
- ALLR 14.63
About SKYQ SKY QUARRY INC
Sky Quarry Inc is a development-stage oil-producing and refining company. The company along with its subsidiaries is engaged in deploying technologies to facilitate the recycling of waste asphalt shingles and remediation of oil-saturated soils. The recycling and production of oil from asphalt shingles is expected to reduce the dependence on landfills for the disposal of waste and to also reduce dependence on foreign and domestic virgin crude oil extraction for industrial uses.
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.